Takao Ukaji

Statistics

Publications

Citations

H-Index

Active since

2018

Affiliations

Japanese Foundation For Cancer Research(Current)

Japan Society of Chemotherapy

Takao Ukaji is an author at Japanese Foundation For Cancer Research specializing in metastatic disease treatment, metastasis, and osteosarcoma treatment.

Publications per year

2018–2025

Publications

Platelet-derived lysophosphatidic acid mediated LPAR1 activation as a therapeutic target for osteosarcoma metastasis

Satoshi Takagi, Yuki Sasaki, Sumie Koike et al. · Oncogene · 2021 · 47 citations · Full text

Medicine, Cell Biology, Oncology +17

Targeting Podoplanin for the Treatment of Osteosarcoma

Ai Takemoto, Satoshi Takagi, Takao Ukaji et al. · Clinical Cancer Research · 2022 · 29 citations · Full text

Medicine, Oncology, Pharmacology +17

A safety study of newly generated anti-podoplanin-neutralizing antibody in cynomolgus monkey (<i>Macaca fascicularis</i>)

Takao Ukaji, Ai Takemoto, Ryohei Katayama et al. · Oncotarget · 2018 · 12 citations · Full text

Medicine, Pharmacology, Cancer Pharmacology +13

AAV-mediated base editing restores cochlear gap junction in GJB2 dominant-negative mutation-associated syndromic hearing loss model

Takao Ukaji, Daisuke Arai, Harumi Tsutsumi et al. · JCI Insight · 2025 · 10 citations · Full text

Life Sciences, Genetics, Molecular Medicine +17

1–4 of 4